IL81045A - Pharmaceutical product for the sustained release of ibuprofen and its preparation - Google Patents

Pharmaceutical product for the sustained release of ibuprofen and its preparation

Info

Publication number
IL81045A
IL81045A IL81045A IL8104586A IL81045A IL 81045 A IL81045 A IL 81045A IL 81045 A IL81045 A IL 81045A IL 8104586 A IL8104586 A IL 8104586A IL 81045 A IL81045 A IL 81045A
Authority
IL
Israel
Prior art keywords
ibuprofen
preparation
sustained release
pharmaceutical product
tablets
Prior art date
Application number
IL81045A
Other languages
English (en)
Other versions
IL81045A0 (en
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of IL81045A0 publication Critical patent/IL81045A0/xx
Publication of IL81045A publication Critical patent/IL81045A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Control Of El Displays (AREA)
  • Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL81045A 1986-06-25 1986-12-19 Pharmaceutical product for the sustained release of ibuprofen and its preparation IL81045A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2553/86A CH669523A5 (xx) 1986-06-25 1986-06-25

Publications (2)

Publication Number Publication Date
IL81045A0 IL81045A0 (en) 1987-03-31
IL81045A true IL81045A (en) 1990-11-05

Family

ID=4236387

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81045A IL81045A (en) 1986-06-25 1986-12-19 Pharmaceutical product for the sustained release of ibuprofen and its preparation

Country Status (18)

Country Link
US (1) US4867987A (xx)
EP (1) EP0250648B1 (xx)
JP (1) JPS635020A (xx)
KR (1) KR930008956B1 (xx)
CN (1) CN1023191C (xx)
AT (1) ATE66370T1 (xx)
AU (1) AU590370B2 (xx)
CA (1) CA1276560C (xx)
CH (1) CH669523A5 (xx)
DE (1) DE3681031D1 (xx)
DK (1) DK616186A (xx)
ES (1) ES2029228T3 (xx)
FI (1) FI88580C (xx)
GR (1) GR3002579T3 (xx)
IL (1) IL81045A (xx)
NO (1) NO173081C (xx)
NZ (1) NZ218734A (xx)
ZA (1) ZA869586B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP1338275B1 (en) * 2000-11-28 2012-02-29 Nartsissov, Yaroslav Pharmaceutical composition, the use thereof and method for producing said composition
DK1551372T3 (en) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
KR101430759B1 (ko) * 2005-02-04 2014-08-19 필립모리스 프로덕츠 에스.에이. 셀룰로오스 풍미 첨가물을 갖는 궐련 및 필터
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
EP1968542B1 (en) * 2005-12-16 2013-08-14 Hanmi Science Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
EP2526932B1 (en) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Pharmaceutical composition
AU2007322269A1 (en) * 2006-10-11 2008-05-29 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP5953646B2 (ja) * 2009-11-24 2016-07-20 大正製薬株式会社 イブプロフェン含有固形製剤
BR112012022797A2 (pt) * 2010-03-09 2018-02-20 Alkermes Pharma Ireland Ltd composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
JPS51127041A (en) * 1975-04-23 1976-11-05 Toyama Chem Co Ltd A process for preparing novel 2-( substituted phenyl) alkane acids and their salts.
US4447454A (en) * 1977-04-01 1984-05-08 The Upjohn Company Analgetic compounds, compositions and process of treatment
CA1125698A (en) * 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
JPS6028809B2 (ja) * 1979-08-21 1985-07-06 日本原子力研究所 イブプロフエン徐放剤組成物の製造方法
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
CH659391A5 (de) * 1982-07-22 1987-01-30 Richardson Vicks Inc Koffein enthaltende, analgetische und antiinflammatorische pharmazeutische zubereitung.
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances

Also Published As

Publication number Publication date
IL81045A0 (en) 1987-03-31
AU6680786A (en) 1988-01-07
ZA869586B (en) 1988-07-27
DE3681031D1 (de) 1991-09-26
EP0250648A3 (en) 1988-03-23
AU590370B2 (en) 1989-11-02
KR930008956B1 (ko) 1993-09-17
CN86108644A (zh) 1988-01-06
CH669523A5 (xx) 1989-03-31
EP0250648B1 (de) 1991-08-21
NO173081C (no) 1993-10-27
FI88580B (fi) 1993-02-26
GR3002579T3 (en) 1993-01-25
NO865195L (no) 1987-12-28
FI865227A (fi) 1987-12-26
FI88580C (fi) 1993-06-10
ES2029228T3 (es) 1992-08-01
ATE66370T1 (de) 1991-09-15
JPS635020A (ja) 1988-01-11
DK616186D0 (da) 1986-12-19
NO865195D0 (no) 1986-12-19
CN1023191C (zh) 1993-12-22
KR880000090A (ko) 1988-03-23
DK616186A (da) 1987-12-26
NZ218734A (en) 1990-03-27
EP0250648A2 (de) 1988-01-07
FI865227A0 (fi) 1986-12-19
NO173081B (no) 1993-07-19
CA1276560C (en) 1990-11-20
US4867987A (en) 1989-09-19

Similar Documents

Publication Publication Date Title
IL81045A0 (en) Pharmaceutical product for the sustained release of ibuprofen and its preparation
AU4657085A (en) High density, delayed release lacquered pharmaceutical pellets
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
GEP20002013B (en) Therapeutical Means
IE881916L (en) Press-coated dihydropyridine tablets
CA2145093A1 (en) Therapeutic inhibitor of vascular smooth muscle cells
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
AU7239996A (en) Inhibition of tumor necrosis factor alpha
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
AU7095687A (en) Pellet-containing pharmaceutical compositions
AU3499389A (en) Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
ZA894422B (en) Pyrrole derivatives,their preparation and their use as pharmaceutical active compounds
MX9705834A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion.
IL90863A0 (en) Annelated indoleketones with an imidazolylalkyl substituent,their preparation and pharmaceutical compositions containing them
GB1302266A (xx)
AU6901191A (en) Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
AU6037494A (en) Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
IL90572A0 (en) Cholestadiene derivatives,process for their preparation and pharmaceutical composition to inhibit hmg-coa reductase
GB1454872A (en) Anticonvulsant
ZA893704B (en) Compounds with central analgesic activity,process for their preparation and pharmaceutical compositions containing them
IE880615L (en) Pharmaceutical composition in beadlet form

Legal Events

Date Code Title Description
RH Patent void